Finance Partner

Henlius is a global, innovation-driven and patient-centric biopharmaceutical company committed to delivering high-quality, affordable biologic therapies to patients worldwide. As we continue to expand in the U.S. and prepare for multiple product launches, we are seeking a highly strategic and hands-on Finance Business Partner to support our US Commercial organization. The Finance Business Partner will serve as a strategic business partner to the US commercial team and become an active voice in decision making within the team. This role is responsible for ensuring delivery of financial commitments by enabling data-driven trade-offs across functions, integrating insights from sales forecasting, launch planning, resource allocation, market access, pricing, and gross-to-net elements. The Finance Business Partner will have the opportunities to support multiple products launches with the commercial team. The FP&A will be the connector to global HQ and US team. The ideal candidate connects financial rigor with operational realities, driving alignment across the business to maximize value, optimize resource allocation, and support sustainable growth. The ideal candidate brings strong financial discipline, deep pharma commercial understanding, and the ability to influence cross-functional decisions in a fast-paced, growth environment. Key Responsibilities Strategic Business Partnership Serve as primary finance partner and work closely with Commercial, Medical, Market Access, Pricing, and Field Leadership to deliver financial targets and provide actionable insights to guide strategic decisions. Support trade-off discussions across initiatives Support launch planning and lifecycle management through scenario modeling, risk assessment, and investment analysis. Provide financial perspectives on key business questions, enabling sound and timely decisions that support growth and value creation. Lead planning processes for the US Commercial organization, including annual budget, quarterly forecasts, long-range plans, and ad hoc scenario analysis. Partner with cross-functional teams on sales forecasting and ensure assumptions are clearly articulated, aligned, and communicated to US and global finance stakeholders. Monitor performance versus plan and identify risks and opportunities early. Build and maintain driver-based models reflecting volume, price, payer mix, access dynamics and commercial investments Translate operational metrics into financial outcomes. Oversee financial planning and month-end tracking for commercial expenses, ensuring accuracy, transparency, and reliability. Gross-to-Net & Revenue Management Provide finance leadership on gross-to-net forecasting and analysis, including rebates, chargebacks, discounts, fees, returns, and reserves Partner with Pricing and Market Access teams to assess contracting strategies, payer dynamics and negotiation, and financial implications of access decisions. In-depth understanding of reserves and owning voluntary reserves decision making and scenario mapping conversations Ensure accurate revenue forecasting and reserve adequacy. Develop insights into net sales performance and key revenue drivers to support proactive business management. Cross-Functional Integration: Connect financial & operational insights across Customer Engagement, Commercial, Medical, and Access & Pricing strategies to support enterprise thinking Facilitate cross-functional discussions to drive alignment on priorities, assumptions, risks, to ensure coordinated decisions across functions. Act as a connector between the US business and global HQ finance team, ensuring visibility, consistency, and strong communication across regions. Support a disciplined, data-driven approach to prioritization and performance management across the commercial organization Governance, Reporting & Decision Support Oversee executive-level reporting on portfolio performance and risks. Support financial reviews, business cases, and investment approvals. Ensure compliance with financial policies and internal controls. Continuously improve planning, forecasting, and reporting processes to enhance business insight and decision speed. Stakeholder Management: Key Stakeholders: Henlius US commercial leaders and global HQ finance team Level of Influence: High; must influence cross-functional stakeholders to align priorities and resources. Exposure: High frequency of managing executive stakeholders with assertiveness and confidence. Requirements Bachelor’s degree in finance, accounting, economics, or related field. 8+ years of progressive finance experience with demonstrated leadership in business partnering and strategic finance Prior experience in pharmaceutical, biotech, or life sciences finance, with strong exposure to US commercial finance. Strong understanding of pharma revenue mechanics (pricing, access, gross-to-net). Strong planning, reporting and analytical skills with demonstrated business and systems impact in previous roles. Comfort working in a fast-moving, resource-constrained organization. Strong analytical skills to work with large datasets from multiple systems to build insights and reporting. Experience using financial systems, including skill with ERP (SAP) Ability to partner effectively with senior cross-functional stakeholders and influence decisions in a matrixed environment. Excellent communication and presentation skills, with the ability to explain financial concepts to non-finance audiences. Preferred Qualifications MBA, CPA, or other advanced finance/business qualification. Experience supporting product launches or launch readiness in the U.S. pharma/biotech market. Experience partnering with Commercial, Market Access, Pricing, or Field organizations in a business-facing finance role. Familiarity with forecasting and performance analytics related to specialty products, oncology, or biologics. Experience working across global organizations and partnering with international or headquarters-based finance teams. Demonstrated ability to build structure, processes, and financial discipline in a growing organization. About Henlius Henlius (2696.HK) is a global biopharmaceutical company with the vision to offer high-quality, affordable and innovative biologic medicines for patients worldwide with a focus on oncology, autoimmune diseases and ophthalmic diseases. Up to date, 10 products have been approved for marketing worldwide, and 5 marketing applications have been accepted for review in China and the EU, respectively. Since its inception in 2010, Henlius has built an integrated biopharmaceutical platform with core capabilities of high-efficiency and innovation embedded throughout the whole product life cycle including R&D, manufacturing and commercialization. It has established global innovation centre and Shanghai-based commercial manufacturing facilities certificated by China, the EU and U.S. GMP. Henlius has pro-actively built a diversified and high-quality product pipeline covering about 50 molecules and has continued to explore immuno-oncology combination therapies with proprietary HANSIZHUANG (anti-PD-1 mAb) as the backbone. To date, the company's launched products include HANSIZHUANG (serplulimab, trade name: Hetronifly® in Europe), the world’s first anti-PD-1 mAb for the first-line treatment of SCLC, HANQUYOU (trastuzumab, trade name: HERCESSI™ in the U.S., Zercepac® in Europe), a China-developed mAb biosimilar approved in China, Europe and U.S., HANLIKANG (rituximab), the first China-developed biosimilar, denosumab Bildyos® and Bilprevda®. and pertuzumab Poherdy®. What’s more, Henlius has conducted over 30 clinical studies for 19 products, expanding its presence in major markets as well as emerging markets. For more information, please visit #J-18808-Ljbffr Henlius USA Inc.